Rowasa 4 g/60mL

Rowasa 4 g/60mL is a rectal suspension containing mesalamine, used for managing inflammatory conditions in the colon. This medication is designed for localized treatment, offering a targeted approach to symptom relief.

Rowasa 4 g/60mL is primarily used for the treatment of ulcerative proctitis, a type of inflammatory bowel disease affecting the rectum. Mesalamine, the active ingredient, helps to reduce inflammation in the colon. This medication is often recommended for individuals experiencing symptoms such as rectal bleeding, diarrhea, and abdominal pain. It is administered rectally, allowing the active ingredient to act directly on the affected area.

Common effects of Rowasa 4 g/60mL may include mild abdominal cramps, bloating, or gas. Some users might experience rectal irritation or discomfort. These effects are generally temporary and should subside as the body adjusts to the medication. If severe or persistent, it is advisable to consult a healthcare provider.

Rowasa 4 g/60mL should be used with caution in individuals with known allergies to mesalamine or other ingredients in the suspension. It is important to follow the prescribed administration instructions to ensure proper use. Keep the medication out of reach of children and store it as directed to maintain its effectiveness.

Rowasa 4 g/60mL may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other drugs that affect the gastrointestinal tract. Alcohol consumption should be avoided as it may exacerbate side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.